Purified photoproducts of merocyanine 540 trigger cytochrome C release and caspase 8-dependent apoptosis in human leukemia and melanoma cells

Blood

Volumn 93, Issue 12, 1999, Pages 4096-4108

  Pervaiz, Shazib ^a   Seyed, Mohamed A ^b   Hirpara, Jayshreekumari L ^b   Clément, Marie Véronique ^b   Loh, Kok W ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYTOCHROME C; MEROCYANINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CYTOPATHOGENIC EFFECT; DRUG DETERMINATION; DRUG PURIFICATION; ENZYME RELEASE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MELANOMA CELL; PRIORITY JOURNAL; TARGET CELL;

EID: 0033564272     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.12.4096     Document Type: Article

References (73)

1. Bossy-Wetzel E, Newmeyer DD, Green DR: Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J 17:37, 1998
2. Bradham CA, Qian T, Streetz K, Trautwein C, Brenner DA, Lemasters JJ: The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol Cell Biol 18:6353, 1998
3. Fearnhead HO, Rodriguez J, Govek EE, Guo W, Kobayashi R, Hannon G, Lazebnik YA: Oncogene-dependent apoptosis is mediated by caspase-9. Proc Natl Acad Sci USA 95:13664, 1998
4. Ferrari D, Stepczynska A, Los M, Wesselborg S, Schulze-Osthoff K: Differential regulation and ATP requirement for caspase-8 and caspase-3 activation during CD95- and anticancer drug-induced apoptosis. J Exp Med 188:979, 1998
5. Fulda S, Scaffidi C, Susin SA, Krammer PH, Kroemer G, Peter ME, Debatin KM: Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J Biol Chem 273:33942, 1998
6. Fulda S, Susin SA, Kroemer G, Debatin KM: Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells. Cancer Res 58:4453, 1998
7. Green DR, Reed JC: Mitochondria and apoptosis. Science 281: 1309, 1998
8. Green D, Kroemer G: The central executioners of apoptosis: Caspases or mitochondria? Trends Cell Biol 8:267, 1998
9. Han J, Modha D, White E: Interaction of E1B 19K with Bax is required to block Bax-induced loss of mitochondrial membrane potential and apoptosis. Oncogene 17:2993, 1998
10. Kroemer G, Dallaporta B, Resche-Rigon M: The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 60:619, 1998
11. Samali A, Zhivotovsky B, Jones DP, Orrenius S: Detection of pro-caspase-3 in cytosol and mitochondria of various tissues. FEBS Lett 431:167, 1998
12. Steemans M, Goossens V, Van de Craen M, Van Herreweghe F, Vancompernolle K, De Vos K, Vandenabeele P, Grooten J: A caspase-activated factor (CAF) induces mitochondrial membrane depolarization and cytochrome c release by a nonproteolytic mechanism. J Exp Med 188:2193, 1998
13. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Brenner C, Larochette N, Provost MC, Alzari PM, Kroemer G: Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp Med 189:381, 1999
14. Finucane DM, Bossy-Wetzel E, Waterhouse NJ, Cotter TG, Green DR: Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by bcl-xL. J Biol Chem 274:2225, 1999
15. Kuwana T, Smith JJ, Muzio M, Dixit V, Newmeyer DD, Kornbluth S: Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. J Biol Chem 273:16589, 1998
16. Marzo I, Susin SA, Petit PX, Ravagnan L, Brenner C, Larochette N, Zamzami N, Kroemer G: Caspases disrupt mitochondrial membrane barrier function. FEBS Lett 427:198, 1998
17. Susin SA, Zamzami N, Kroemer G: Mitochondria as regulators of apoptosis: Doubt no more. Biochim Biophys Acta 1366:151, 1998
18. Decaudin D, Marzo I, Brenner C, Kroemer G: Mitochondria in chemotherapy-induced apoptosis: A prospective novel target of cancer therapy (Review). Int J Oncol 12:141, 1998
19. Uehara T, Kikuchi Y, Nomura Y: Caspase activation accompanying cytochrome c release from mitochondria is possibly involved in nitric oxide-induced neuronal apoptosis in SH-SY5Y cells. J Neurochem 72:196, 1999
20. Thornberry NA, Lazebnik Y: Caspases: Enemies within. Science 281:1312, 1998
21. Alnemri ES: Mammalian cell death proteases: A family of highly conserved aspartate specific cysteine proteases. J Cell Biochem 64:33, 1997
22. Brancolini C, Lazarevic D, Rodriguez J, Schneider C: Dismantling cell-cell contacts during apoptosis is coupled to a caspase-dependent proteolytic cleavage of beta-catenin. J Cell Biol 139:759, 1997
23. Duriez PJ, Shah GM: Cleavage of poly(ADP-ribose) polymerase: A sensitive parameter to study cell death. Biochem Cell Biol 75:337, 1997
24. Rao L, Perez D, White E: Lamin proteolysis facilitates nuclear events during apoptosis. J Cell Biol 135:1441, 1996
25. Porter AG, Ng P, Janicke RU: Death substrates come alive. Bioessays 19:501, 1997
26. Datta R, Banach D, Kojima H, Talanian RV, Alnemri ES, Wong WW, Kufe DW: Activation of the CPP32 protease in apoptosis induced by 1-beta-D-arabinofuranosylcytosine and other DNA-damaging agents. Blood 88:1936, 1996
27. Dubrez L, Savoy I, Hamman A, Solary E: Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways. EMBO J 15:5504, 1996
28. Eischen CM, Kottke TJ, Martins LM, Basi GS, Tung JS, Earnshaw WC, Leibson PJ, Kaufmann SH: Comparison of apoptosis in wild-type and Fas-resistant cells: Chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood 90:935, 1997
29. Benjamin CW, Hiebsch RR, Jones DA: Caspase activation in MCF7 cells responding to etoposide treatment. Mol Pharmacol 53:446, 1998
30. Gamen S, Anel A, Lasierra P, Alava MA, Martinez-Lorenzo MJ, Pineiro A, Naval J: Doxorubicin-induced apoptosis in human T-cell leukemia is mediated by caspase-3 activation in a Fas-independent way. FEBS Lett 417:360, 1997
31. Jacobsen MD, Weil M, Raff MC: Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death. J Cell Biol 133:1041, 1996
32. Nita ME Nagawa H, Tominaga O, Tsuno N, Fujii S, Sasaki S, Fu CG, Takenoue T, Tsuruo T, Muto T: 5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins. Br J Cancer 78:986, 1998
33. Pervaiz S, Hirpara JL, Clement M-V: Caspase proteases mediate apoptosis induced by anti-cancer agent preactivated MC540 in human tumor cell lines. Cancer Lett 127:1, 1998
34. Hirata H, Takahashi A, Kobayashi S, Yonehara S, Sawai H, Okazaki T, Yamamoto K, Sasada M: Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med 187:587, 1998
35. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME: Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17:1675, 1998
36. Bernardi P: The permeability transition pore. Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death. Biochim Biophys Acta 1275:5, 1996
37. Bernardi P, Petronilli V: The permeability transition pore as a mitochondrial calcium release channel: A critical appraisal. J Bioenerg Biomembr 28:131, 1996
38. Zoratti M, Szabo I: The mitochondrial permeability transition. Biochim Biophys Acta 1241:139, 1995
39. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD: The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 275:1132, 1997
40. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M, Kroemer G: Mitochondrial control of nuclear apoptosis. J Exp Med 183:1533, 1996
41. Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotte B, Kroemer G: Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 182:367, 1995
42. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere J, Petit PX, Kroemer G: Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 181:1661, 1995
43. Troyan MB, Oilman VR, Gay CV: Mitochondrial membrane potential changes in obseoblasts treated with parathyroid hormone and estradiol. Poultry Sci 233:247, 1997
44. Marzo I, Brenner C, Zamzami N, Susin SA, Beutner G, Brdiczka D, Remy R, Xie Z, Reed JC, Kroemer G: The permeability transition pore complex: A target for apoptosis regulation by caspases and Bcl-2-related proteins. J Exp Med 187:1261, 1998
45. Marzo I, Brenner C, Zamzami N, Jurgensmeier JM, Susin SA, Vieira HL, Prevost MC, Xie Z, Matsuyama S, Reed JC, Kroemer G: Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281:2027, 1998
46. Nicolli A, Petronilli V, Bernardi P: Modulation of the mitochondrial cylosporin A-sensitive permeability transition pore by Matric pH. Evidence that the pore open-closed probability is regulated by Histidine protonation. J Biol Chem 32:4461, 1993
47. Narita M, Shimizu S, Ito T, Chittenden T, Lutz RJ, Matsuda H, Tsujimoto Y: Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci USA 95:14681, 1998
48. Bernardi P, Vassanelli S, Veronese P, Colonna R, Szabo I, Zoratti M: Modulation of the mitochondrial permeability transition pore. J Biol Chem 267:2934, 1992
49. Bernardi P, Veronese P, Petronilli V: Modulation of the mitochondria cyclosporin A-sensitive permeability transition pore. J Biol Chem 268:1005, 1993
50. Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A, Haeffner A, Hirsch F, Geuskens M, Kroemer G: Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 184:1155, 1996
51. Krammer PH, Behrmann I, Daniels P, Dhein J, Debatin K-M: Regulation of apoptosis in the immune system. Curr Opin Immunol 6:279, 1994
52. Chemyak BV, Bernardi P: The mitochondrial permeability transition pore is modulated by oxidative agents through both pyridine nucleotides and glutathione at two separate sites. Eur J Biochem 238:623, 1996
53. Gulliya KS, Pervaiz S, Dowben RM, Matthews JL: Tumor cell specific dark cytotoxicity of light-exposed merocyanine 540: Implications for systemic therapy without light. Photochem Photobiol 52:831, 1990
54. Gulliya KS, Sharma RK, Matthews JL, Benniston AC, Harriman A, Nemunaitis JJ: In vitro and in vivo growth suppression of MCF-7 human breast cancer by novel photoproducts and tamoxifen. Cancer 74:1725, 1994
55. Wiggs RB, Lobprise HB, Matthews JL, Gulliya KS: Effects of preactivated MC540 in the treatment of lymphocytic plasmacytic stomatitis in feline leukemia virus and feline immunodeficiency virus positive cats. J Vet Dent 10:9, 1993
56. Petit PX, O'Connor JE, Grunwald D, Brown SC: Analysis of the membrane potential of rat- and mouse-liver mitochondria by flow cytometry and possible applications. Eur J Biochem 194:389, 1990
57. Franck B, Schneider U: Photooxidation products of merocyanine 540 formed under preactivation conditions for tumor therapy. Photochem Photobiol 56:271, 1992
58. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, Green DR: Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182:1545, 1995
59. Simizu S, Takada M, Umezawa K, Imoto M: Requirement of caspase-3(-like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs. J Biol Chem 273:26900, 1998
60. Juo P, Kuo CJ, Yuan J, Blenis J: Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Curr Biol 8:1001, 1998
61. Li H, Zhu H, Xu C, Yuan J: Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491, 1998
62. Fulda S, Friesen C, Los M, Scaffidi C, Mier W, Benedict M, Nunez G, Krammer PH, Peter ME, Debatin KM: Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res 57:4956, 1997
63. Clement M-V, Stamenkovic I: Superoxide anion is a natural inhibitor of Fas-mediated cell death. EMBO J 15:216, 1996
64. Stennicke HR, Jurgensmeier JM, Shin H, Deveraux Q, Wolf BB, Yang X, Zhou Q, Ellerby HM, Ellerby LM, Bredesen D, Green DR, Reed JC, Froelich CJ, Salvesen GS: Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem 273:27084, 1998
65. Scarlett JL, Murphy MP: Release of apoptogenic proteins from the mitochondrial intermembrane space during the mitochondrial permeability transition. FEBS Lett 418:282, 1997
66. Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES, Green DR, Martin SJ: Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 144:281, 1999
67. Susin SA, Zamzami N, Castedo M, Daugas E, Wang HG, Geley S, Fassy F, Reed JC, Kroemer G: The central executioner of apoptosis: Multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis. J Exp Med 186:25, 1997
68. Marchetti P, Hirsch T, Zamzami N, Castedo M, Decaudin D, Susin SA, Masse B, Kroemer G: Mitochondrial permeability transition triggers lymphocyte apoptosis. J Immunol 157:4830, 1996
69. Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT, Thompson CB: Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91:627, 1997
70. Mancini M, Nicholson DW, Roy S, Thornberry NA, Peterson EP, Casciola-Rosen LA, Rosen A: The caspase-3 precursor has a cytosolic and mitochondrial distribution: Implications for apoptotic signaling. J Cell Biol 140:1485, 1998
71. Jurgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D, Reed JC: Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA 95:4997, 1998
72. Gross A, Yin XM, Wang K, Wei MC, Jockel J, Milliman C, Erdjument-Bromage H, Tempst P, Korsmeyer SJ: Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 274:1156, 1999
73. Luo X, Budihardjo I, Zuo H, Slaughter C, Wang X: Bid, a Bcl2 interacing protein, medicates cytochome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481, 1998